Open Access<p>Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study</p>
Author(s) -
Youxin Chen,
Xiaoxin Li,
Young Hee Yoon,
Xiaodong Sun,
Yury S. Astakhov,
Gezhi Xu,
Hui Wang,
Xiaowei Ren,
Friedrich Asmus,
VIVID-East investigators
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s235267
Subject(s) - medicine , aflibercept , ophthalmology , macular edema , diabetic macular edema , randomized controlled trial , clinical endpoint , visual acuity , diabetic retinopathy , diabetes mellitus , laser coagulation , retinal , adverse effect , edema , surgery , bevacizumab , chemotherapy , endocrinology
The prevalence of diabetes and diabetes-related complications, including diabetic macular edema (DME), is increasing in Asia and worldwide.